Latent TB Detection Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Latent TB Detection Market is estimated to grow at a CAGR of 5% during the forecast period 2022-2028.

Latent tuberculosis bacteria exist in an inactive state in the body. Infected people do not get sick, have no symptoms, and cannot transmit the disease to others. However, bacteria can become active at certain points in time. Tuberculosis (TB) can remain dormant for years before developing into active tuberculosis. This condition is called latent tuberculosis. Diagnosis is essential because latent tuberculosis develops into infectious tuberculosis when the immune system is weakened.

Market Segments

By Test

• Tuberculin Skin Test (TST)
• Interferon Gamma Released Assay (IGRA)

By End User

• Hospitals
• Diagnostic Centers
• Laboratories

Key Players

• QIAGEN
• BioMeriux S.A.
• F. Hoffmann La-Roche Ltd.
• ARKRAY, Inc.
• Abbott
• Serum Institute of India Pvt. Ltd.
• Oxford Immunotec Ltd.
• Lionex GmbH
• Autoimmune Diagnostic GMBH

Scope of the Report

The research study analyzes the global Latent TB Detection industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Latent TB Detection Market Report

1. What was the Latent TB Detection Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Latent TB Detection Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Latent TB Detection Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.